Brain trauma induced hyperfibrinolysis: a tale of two cases diagnosed on wheels of rotational thromboelastometry
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253635Keywords:
Brain injury, Hyperfibrinolysis, Rotational thromboelastometryAbstract
Brain trauma including brain surgeries are medical emergencies which frequently cause abnormalities in the coagulation system which in turn leads to bleeding and poor outcomes. Routine coagulation tests often fail to diagnose these defects in the coagulation/fibrinolytic system in such critical emergencies. Viscoelastic tests are a rapid alternative which not only helps to diagnose these patients accurately but also at a much earlier time than routine coagulation tests. Here, we report two cases of brain surgeries who presented with bleeding in post operative period due to hyperfibrinolysis and they were correctly diagnosed and successfully treated with the help of rotational thomboelastometry whereas routine coagulation tests failed to do so.
Metrics
References
Gando S, Wada H, Thachil J, Scientific Standardization Committee on DIC of the International Society on Thrombosis and Hemostasis. Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS). J Thromb Hemost. 2013;11:826-35. DOI: https://doi.org/10.1111/jth.12190
Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI. Coagulation disorders after traumatic brain injury. Acta Neurochir. 2008;150:165-75. DOI: https://doi.org/10.1007/s00701-007-1475-8
Gonzalez E, Moore EE, Moore HB, Chapman MP, Chin TL, Ghasabyan A, et al. Goal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays. Ann Surg. 2016;263(6):1051-9. DOI: https://doi.org/10.1097/SLA.0000000000001608
Nakae R, Murai Y, Wada T, Fujiki Y, Kanaya T, Takayama Y, et al. Hyperfibrinolysis and fibrinolysis shutdown in patients with traumatic brain injury. Sci Rep. 2022;12(1):19107. DOI: https://doi.org/10.1038/s41598-022-23912-4
Goodnight SH, Kenoyer G, Rapaport SI, Patch MJ, Lee JA, Kurze T. Defibrination after brain-tissue destruction: A serious complication of head injury. N Engl J Med. 1974;290(19):1043-7. DOI: https://doi.org/10.1056/NEJM197405092901903
Keimowitz RM, Annis BL. Disseminated intravascular coagulation associated with massive brain injury. J Neurosurg. 1973;39(2):178-80. DOI: https://doi.org/10.3171/jns.1973.39.2.0178
Dietrich WD, Alonso O, Halley M. Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J Neurotrauma. 1994;11(3):289-301. DOI: https://doi.org/10.1089/neu.1994.11.289
Chapman MP, Moore EE, Moore HB, Gonzalez E, Gamboni F, Chandler JG, et al. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients. J Trauma Acute Care Surg. 2016;80(1):16-23. DOI: https://doi.org/10.1097/TA.0000000000000885
Karri J, Cardenas JC, Matijevic N, Wang YW, Choi S, Zhu L, et al. Early Fibrinolysis Associated with Hemorrhagic Progression Following Traumatic Brain Injury. Shock. 2017;48(6):644-650. DOI: https://doi.org/10.1097/SHK.0000000000000912
Sillen M, Declerck PJ. A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? Int J Mol Sci. 2021;22(5):2721. DOI: https://doi.org/10.3390/ijms22052721
Tian HL, Chen H, Wu BS, Cao HL, Xu T, Hu J, et al. D-dimer as a predictor of progressive hemorrhagic injury in patients with traumatic brain injury: analysis of 194 cases. Neurosurg Rev. 2010;33(3):359-65. DOI: https://doi.org/10.1007/s10143-010-0251-z
CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32. DOI: https://doi.org/10.1016/S0140-6736(10)60835-5
CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713-23. DOI: https://doi.org/10.1016/S0140-6736(19)32233-0